Dosimetría personalizada a trabajadores y pacientes en procedimientos de Medicina Nuclear con nuevos radiofármacos teranósticos
Loading...
Download
Official URL
Full text at PDC
Publication date
2024
Defense date
17/05/2024
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Complutense de Madrid
Citation
Abstract
La Medicina Nuclear ha experimentado un notable crecimiento en la última década, impulsado por avances en teranóstica y mejoras en sistemas de imagen, lo que ha llevado a un incremento de la oferta y demanda de radiofármacos teranósticos. Aunque esta tendencia representa beneficios significativos para los pacientes, también plantea desafíos y consideraciones que deben abordarse de manera adecuada. El personal de Medicina Nuclear está diariamente expuesto a altas dosis, especialmente en las extremidades durante el manejo manual de fuentes emisoras de partículas, predominantes entre los radiofármacos terapéuticos...
Nuclear Medicine has experienced remarkable growth in the last decade, driven by advancements in theranostics and improvements in imaging systems, leading to an increase in the supply and demand for theranostic radiopharmaceuticals. While this trend represents significant benefits for patients, it also poses challenges and considerationsthat need to be adequately addressed. Personnel in Nuclear Medicine are daily exposed to high doses, especially to the extremities during manual handling of particle-emitting sources, predominant among therapeutic radiopharmaceuticals...
Nuclear Medicine has experienced remarkable growth in the last decade, driven by advancements in theranostics and improvements in imaging systems, leading to an increase in the supply and demand for theranostic radiopharmaceuticals. While this trend represents significant benefits for patients, it also poses challenges and considerationsthat need to be adequately addressed. Personnel in Nuclear Medicine are daily exposed to high doses, especially to the extremities during manual handling of particle-emitting sources, predominant among therapeutic radiopharmaceuticals...
Description
Tesis inédita de la Universidad Complutense de Madrid, Facultad de Medicina, leída el 17-05-2024. Tesis formato europeo (compendio de artículos)